Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DeLuca

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
American Journal of Pharmaceutical Education|September 11, 2021
Enhancing Pharmacy Faculty Well-Being and Productivity While Reducing BurnoutDaniel R Kennedy, Peter Clapp, Judith L DeLuca, et al.
Nature Protocols|June 8, 2013
Small-molecule ligand docking into comparative models with RosettaSteven A Combs, Samuel L Deluca, Stephanie H Deluca, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid ArthritisJing Cui, Dorothee Diogo, Eli A Stahl, et al.
Plos One|April 8, 2015
TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traitsDorothée Diogo, Lisa Bastarache, Katherine P Liao, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
American Journal of Pharmaceutical Education|September 11, 2021
Enhancing Pharmacy Faculty Well-Being and Productivity While Reducing BurnoutDaniel R Kennedy, Peter Clapp, Judith L DeLuca, et al.
Nature Protocols|June 8, 2013
Small-molecule ligand docking into comparative models with RosettaSteven A Combs, Samuel L Deluca, Stephanie H Deluca, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid ArthritisJing Cui, Dorothee Diogo, Eli A Stahl, et al.
Plos One|April 8, 2015
TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traitsDorothée Diogo, Lisa Bastarache, Katherine P Liao, et al.
Pageof 4